Publications

Yang, Sen, Dongfang Tang, Yu Chen Zhao, Hongliang Liu, Sheng Luo, Thomas E. Stinchcombe, Carolyn Glass, et al. “Potentially functional variants of ERAP1, PSMF1 and NCF2 in the MHC-I-related pathway predict non-small cell lung cancer survival.” Cancer Immunol Immunother 70, no. 10 (October 2021): 2819–33. https://doi.org/10.1007/s00262-021-02877-9.

PMID
33651148
Full Text

Mu, Rui, Hongliang Liu, Sheng Luo, Edward F. Patz, Carolyn Glass, Li Su, Mulong Du, David C. Christiani, Lei Jin, and Qingyi Wei. “Genetic variants of CHEK1, PRIM2 and CDK6 in the mitotic phase-related pathway are associated with nonsmall cell lung cancer survival.” Int J Cancer 149, no. 6 (September 15, 2021): 1302–12. https://doi.org/10.1002/ijc.33702.

PMID
34058013
Full Text

Schmidt, Florian, Bobby Ranjan, Quy Xiao Xuan Lin, Vaidehi Krishnan, Ignasius Joanito, Mohammad Amin Honardoost, Zahid Nawaz, et al. “RCA2: a scalable supervised clustering algorithm that reduces batch effects in scRNA-seq data.” Nucleic Acids Res 49, no. 15 (September 7, 2021): 8505–19. https://doi.org/10.1093/nar/gkab632.

PMID
34320202
Full Text

Klempner, Samuel J., Johanna C. Bendell, Victoria Meucci Villaflor, Laura L. Tenner, Stacey M. Stein, James B. Rottman, Girish S. Naik, et al. “Safety, Efficacy, and Biomarker Results from a Phase Ib Study of the Anti-DKK1 Antibody DKN-01 in Combination with Pembrolizumab in Advanced Esophagogastric Cancers.” Mol Cancer Ther, September 4, 2021. https://doi.org/10.1158/1535-7163.MCT-21-0273.

PMID
34482288
Full Text

Spees, Lisa P., Stephanie B. Wheeler, Bradford E. Jackson, Christopher D. Baggett, Lauren E. Wilson, Melissa A. Greiner, Deborah R. Kaye, et al. “Provider- and patient-level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma.” Cancer Med, September 4, 2021. https://doi.org/10.1002/cam4.4201.

PMID
34480518
Full Text

Wetzel-Strong, Sarah E., Shantel Weinsheimer, Jeffrey Nelson, Ludmila Pawlikowska, Dewi Clark, Mark D. Starr, Yingmiao Liu, et al. “Pilot investigation of circulating angiogenic and inflammatory biomarkers associated with vascular malformations.” Orphanet J Rare Dis 16, no. 1 (September 3, 2021): 372. https://doi.org/10.1186/s13023-021-02009-7.

PMID
34479577
Full Text

Hanson, Erik D., Cameron K. Stopforth, Mohamdod Alzer, Jackson Carver, Alexander R. Lucas, Young E. Whang, Matthew I. Milowsky, et al. “Body composition, physical function and quality of life in healthy men and across different stages of prostate cancer.” Prostate Cancer Prostatic Dis 24, no. 3 (September 2021): 725–32. https://doi.org/10.1038/s41391-020-00317-w.

PMID
33495569
Full Text

Fong, Lawrence, Michael J. Morris, Oliver Sartor, Celestia S. Higano, Lance Pagliaro, Ajjai Alva, Leonard J. Appleman, et al. “A Phase Ib Study of Atezolizumab with Radium-223 Dichloride in Men with Metastatic Castration-Resistant Prostate Cancer.” Clin Cancer Res 27, no. 17 (September 1, 2021): 4746–56. https://doi.org/10.1158/1078-0432.CCR-21-0063.

PMID
34108181
Full Text

Hanson, Erik D., Lauren C. Bates, Elizabeth P. Harrell, David B. Bartlett, Jordan T. Lee, Chad W. Wagoner, Mohamdod S. Alzer, et al. “Exercise training partially rescues impaired mucosal associated invariant t-cell mobilization in breast cancer survivors compared to healthy older women.” Exp Gerontol 152 (September 2021): 111454. https://doi.org/10.1016/j.exger.2021.111454.

PMID
34146655
Full Text

Dieffenbach, Bryan V., Qi Liu, Andrew J. Murphy, Deborah R. Stein, Natalie Wu, Arin L. Madenci, Wendy M. Leisenring, et al. “Late-onset kidney failure in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.” Eur J Cancer 155 (September 2021): 216–26. https://doi.org/10.1016/j.ejca.2021.06.050.

PMID
34391054
Full Text

Pages